背景:先前的研究提供了体内代谢产物与乳腺癌(BC)相关的证据。然而,血液代谢产物与BC之间的因果关系尚不清楚.
方法:本研究进行了孟德尔双样本综合随机分析,以确定1400个公开的代谢因子遗传数据与人类表皮生长因子受体阳性(HER+)BC或HER-BC之间的因果关系。
结果:硫酸表雄酮水平(OR=1.07,95%CI=1.02〜1.10,p=0.0013),5α-雄性激素-3β,17β-二醇单硫酸盐(2)水平(OR=1.07,95%CI=1.03~1.12,p=0.0012),糖胆酸水平(OR=0.85,95%CI=0.77〜0.93,p=0.0007)和乙胆醇酮葡糖苷酸水平(OR=1.12,95%CI=1.05〜1.20,p=0.0013)与HERBC有因果关系。5种代谢物与HER-BC有因果关系:香草酸甘氨酸水平(OR=1.14,95%CI=1.06~1.22,p=0.0003),甲状腺素水平(OR=1.26,95%CI=1.11~1.44,p=0.0004),1-棕榈酰-2-亚油酰基-GPI(16:0/18:2)水平(OR=0.86,95%CI=0.79~0.94,p=0.0010),N-乙酰苯丙氨酸水平(OR=1.12,95%CI=1.05~1.19,p=0.0007)和葡萄糖-甘露糖比值(OR=1.15,95%CI=1.06~1.24,p=0.0008)。确定了两种常见的因果关系代谢物:γ-谷氨酰谷氨酸和X-12849水平。
结论:我们的研究通过遗传手段分别证明了血液代谢产物与HER+或HER-BC之间的联系,从而为治疗目标提供机会。
BACKGROUND: Previous studies provide evidence that in vivo metabolites are associated with breast cancer (BC). However, the causal relationship between blood metabolites and BC remains unclear.
METHODS: Comprehensive two-sample Mendelian randomization analysis was conducted to determine the causal association between 1400 publicly available genetic data on metabolic factors and human epidermal growth factor receptor positive (
HER+) BC or
HER- BC in this study.
RESULTS: Epiandrosterone sulfate levels (OR = 1.07, 95% CI = 1.02 ~ 1.10, p = 0.0013), 5alpha-androstan-3beta,17beta-diol monosulfate (2) levels (OR = 1.07, 95% CI = 1.03 ~ 1.12, p = 0.0012), glycohyocholate levels (OR = 0.85, 95% CI = 0.77 ~ 0.93, p = 0.0007) and etiocholanolone glucuronide levels (OR = 1.12, 95% CI = 1.05 ~ 1.20, p = 0.0013) were causally correlated with HER+ BC. 5 metabolites were causally correlated with
HER- BC: Vanillic acid glycine levels (OR = 1.14, 95% CI = 1.06 ~ 1.22, p = 0.0003), Thyroxine levels (OR = 1.26, 95% CI = 1.11 ~ 1.44, p = 0.0004), 1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) levels (OR = 0.86, 95% CI = 0.79 ~ 0.94, p = 0.0010), N-acetylphenylalanine levels (OR = 1.12, 95% CI = 1.05 ~ 1.19, p = 0.0007) and Glucose-to-mannose ratio (OR = 1.15, 95% CI = 1.06 ~ 1.24, p = 0.0008). Two common causally related metabolites were identified: Gamma-glutamyl glutamate and X-12849 levels.
CONCLUSIONS: Our study has respectively demonstrated the connection between blood metabolites and
HER+ or
HER- BC by genetic means, thereby offering opportunities for therapeutic targets.